SCHEMBL9516149

SCHEMBL9516149

O=C(NS(=O)(=O)c1ccc(Oc2cccc(F)c2)cc1)c1ccc(CO)nc1

nearest known ligand 0.53

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ MCL1 Q07820 12/20 0.53
▸ BCL2L1 Q07817 11/20 0.53
▸ MMP1 P03956 1/20 0.46
▸ MMP13 P45452 1/20 0.46
▸ P4HTM Q9NXG6 3/20 0.44
▸ PTGS2 P35354 2/20 0.44
▸ PTGS1 P23219 1/20 0.44
▸ EGFR P00533 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9515728 0.93 P4HTM (0.45) MCL1BCL2L1P4HTMPTGS2PTGS1
SCHEMBL9519096 0.90 BCL2L1 (0.53) MCL1BCL2L1P4HTMPTGS2PTGS1
SCHEMBL9516981 0.90 BCL2L1 (0.60) MCL1BCL2L1MMP1MMP13P4HTM
SCHEMBL9519730 0.88 MCL1 (0.62) MCL1BCL2L1MMP1MMP13P4HTM
SCHEMBL9516995 0.88 MCL1 (0.49) MCL1BCL2L1MMP1MMP13P4HTM
SCHEMBL9516252 0.87 BCL2L1 (0.50) MCL1BCL2L1MMP13P4HTMEGFR
SCHEMBL9517006 0.84 EGFR (0.50) MCL1BCL2L1P4HTMPTGS2PTGS1
SCHEMBL9517198 0.83 EGFR (0.62) MCL1BCL2L1MMP1P4HTMPTGS2
SCHEMBL9517224 0.82 BCL2L1 (0.49) MCL1BCL2L1MMP1MMP13P4HTM
SCHEMBL9515436 0.82 BCL2L1 (0.56) MCL1BCL2L1P4HTMPTGS2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1079466-A 4-or 5-(sulphur) acylimino-and (inferior sulphur) amidopyridine and pyridine-N-oxide thereof HOECHST AG (DE) 1993-12-15 — — CN disclosed
EP-0567997-A1 4- or 5-(sulf)imido- and (sulfon)amidopyridines and their pyridine-N-oxides, process for their preparation and their use as pharmaceutical HOECHST AKTIENGESELLSCHAFT (DE) 1993-11-03 — — EP disclosed
Send feedback